Transaction DateRecipientSharesTypePriceValue
20th October 2020Capital Viii, Llc Vivo523,726Conversion of derivative$0.00
20th October 2020Capital Viii, Llc Vivo1,885,611Conversion of derivative$0.00
20th October 2020Capital Viii, Llc Vivo66,733Open or private purchase$15.00$1,000,995.00
20th October 2020Capital Viii, Llc Vivo224,054Conversion of derivative$0.00
20th October 2020Capital Viii, Llc Vivo72,320Conversion of derivative$0.00
20th October 2020Capital Viii, Llc Vivo260,380Conversion of derivative$0.00
20th October 2020Capital Viii, Llc Vivo483,267Open or private purchase$15.00$7,249,005.00
20th October 2020Capital Viii, Llc Vivo30,939Conversion of derivative$0.00
16th September 2020Sciences Llc Tardi Med100,694Open or private sale$1.03$103,694.68
15th September 2020Sciences Llc Tardi Med87,060Open or private sale$1.03$89,549.92
Bio Pharm X
Bio Pharm X logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 5/10.


BioPharmX Corp. engages in the provision of healthcare products through platform technologies for pharmaceutical, over-the-counter, and supplement applications in dermatology. The company was founded by James R. Pekarsky and Anja B. Krammer on August 30, 2010.


Ticker: BPMX
Sector: Producer Manufacturing
Industry: Miscellaneous Manufacturing
SEC Central Index Key (CIK): 1504167
Employees: 3
Exchange: NYSE American
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals